Your browser doesn't support javascript.
loading
Inhibition of IL17A Using an Affibody Molecule Attenuates Inflammation in ApoE-Deficient Mice.
Kumawat, Ashok Kumar; Zegeye, Mulugeta M; Paramel, Geena Varghese; Baumgartner, Roland; Gisterå, Anton; Amegavie, Obed; Hellberg, Sanna; Jin, Hong; Caravaca, April S; Söderström, Leif Å; Gudmundsdotter, Lindvi; Frejd, Fredrik Y; Ljungberg, Liza U; Olofsson, Peder S; Ketelhuth, Daniel F J; Sirsjö, Allan.
Afiliação
  • Kumawat AK; Cardiovascular Research Centre, School of Medical Sciences, Örebro University, Orebro, Sweden.
  • Zegeye MM; Cardiovascular Research Centre, School of Medical Sciences, Örebro University, Orebro, Sweden.
  • Paramel GV; Cardiovascular Research Centre, School of Medical Sciences, Örebro University, Orebro, Sweden.
  • Baumgartner R; Division of Cardiovascular Medicine, Department of Medicine, Solna, Centre for Molecular Medicine, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden.
  • Gisterå A; Division of Cardiovascular Medicine, Department of Medicine, Solna, Centre for Molecular Medicine, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden.
  • Amegavie O; Cardiovascular Research Centre, School of Medical Sciences, Örebro University, Orebro, Sweden.
  • Hellberg S; Division of Cardiovascular Medicine, Department of Medicine, Solna, Centre for Molecular Medicine, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden.
  • Jin H; Division of Cardiovascular Medicine, Department of Medicine, Solna, Centre for Molecular Medicine, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden.
  • Caravaca AS; Division of Cardiovascular Medicine, Department of Medicine, Solna, Centre for Molecular Medicine, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden.
  • Söderström LÅ; Division of Cardiovascular Medicine, Department of Medicine, Solna, Centre for Molecular Medicine, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden.
  • Gudmundsdotter L; Affibody AB, Solna, Sweden.
  • Frejd FY; Affibody AB, Solna, Sweden.
  • Ljungberg LU; Cardiovascular Research Centre, School of Medical Sciences, Örebro University, Orebro, Sweden.
  • Olofsson PS; Division of Cardiovascular Medicine, Department of Medicine, Solna, Centre for Molecular Medicine, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden.
  • Ketelhuth DFJ; Division of Cardiovascular Medicine, Department of Medicine, Solna, Centre for Molecular Medicine, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden.
  • Sirsjö A; Department of Cardiovascular and Renal Research, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark.
Front Cardiovasc Med ; 9: 831039, 2022.
Article em En | MEDLINE | ID: mdl-35282365
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Cardiovasc Med Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Suécia
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Cardiovasc Med Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Suécia